1h Free Analyst Time
The oncology market in India is forecast to grow by USD 947.84 mn during 2022-2027, accelerating at a CAGR of 13.45% during the forecast period. The report on the oncology market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increased prevalence of cancer, the need for cost-cutting in drug discovery and development, and the increasing demand for precision medicine.
The oncology market is segmented as below:
By Type
- Cancer treatment
- Cancer diagnostics
By End-user
- Hospitals
- Diagnostic laboratories
- Diagnostic imaging centers
- Others
The report on the oncology market covers the following areas:
- Oncology market sizing
- Oncology market forecast
- Oncology market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global oncology market : 3M Co., Abbott Laboratories, Alkem Laboratories Ltd., AstraZeneca Plc, Baxter International Inc., Bristol Myers Squibb Co., Cipla Ltd., F. Hoffmann La Roche Ltd., GE Healthcare Technologies Inc., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Medtronic Plc, Merck and Co. Inc., NATCO Pharma Ltd., Novartis AG, Poly Medicure Ltd., Siemens Healthineers AG, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is a rise in R&D.`
According to the report, one of the major drivers for this market is the increased prevalence of cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Co.
- Abbott Laboratories
- Alkem Laboratories Ltd.
- AstraZeneca Plc
- Baxter International Inc.
- Bristol Myers Squibb Co.
- Cipla Ltd.
- F. Hoffmann La Roche Ltd.
- GE Healthcare Technologies Inc.
- Glenmark Pharmaceuticals Ltd.
- Lupin Ltd.
- Medtronic Plc
- Merck and Co. Inc.
- NATCO Pharma Ltd.
- Novartis AG
- Poly Medicure Ltd.
- Siemens Healthineers AG
- Sun Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.
- Zydus Lifesciences Ltd.